Characteristic | Overall (n = 8) | |
---|---|---|
Age (years, Median (Q1,Q3)) | 24.5 (20.2,34.5) | |
Gender | Male | 7 (87.5%) |
Female | 1 (12.5%) | |
Performance Status | 0 | 6 (75.0%) |
1 | 2 (25.0%) | |
Histology/Cytological type | Chondroblastic OS 9181/3 | 1 (12.5%) |
Osteoblastic OS 9180/3 | 2 (25.0%) | |
Osteosarcoma NOS 9180/3 | 5 (62.5%) | |
Primary Site | axial | 3 (37.5%) |
limb | 5 (62.5%) | |
Disease stage at screening | metastatic | 8 (100.0%) |
Tumour size at baseline (sum of longest diameters) (mm) | 82.0 (51.0,92.0) | |
Prior radiotherapy | yes | 2 (25.0%) |
no | 6 (75.0%) | |
Prior chemotherapy | yes | 8 (100.0%) |
no | 0 (0.0%) | |
Prior surgery | yes | 8 (100.0%) |
no | 0 (0.0%) |